PHS
ELGX

PFM Health Sciences’s Endologix Inc ELGX Stock Holding History

PFM Health Sciences’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-159,285
Closed -$252K – 87
2019
Q4 		$252K Sell
159,285
-94,605
-37% -$265K 0.01% 61
2019
Q3 		$1.01M Buy
+253,890
New +$1.48M 0.03% 71
2018
Q4 		– Sell
-740,859
Closed -$14.2M – 136
2018
Q3 		$14.2M Sell
740,859
-13,357
-2% -$477K 0.21% 100
2018
Q2 		$42.7M Sell
754,216
-20,077
-3% -$1.02M 0.67% 58
2018
Q1 		$32.8M Buy
774,293
+23,302
+3% +$1M 0.67% 57
2017
Q4 		$40.2M Buy
750,991
+85,093
+13% +$4.49M 0.95% 45
2017
Q3 		$29.7M Buy
665,898
+105,951
+19% +$4.83M 0.58% 58
2017
Q2 		$27.2M Buy
559,947
+355,568
+174% +$20.9M 0.73% 47
2017
Q1 		$14.8M Buy
204,379
+94,728
+86% +$6.27M 0.37% 75
2016
Q4 		$6.27M Buy
109,651
+56,081
+105% +$5.14M 0.18% 84
2016
Q3 		$6.86M Sell
53,570
-102,324
-66% -$13.1M 0.2% 79
2016
Q2 		$19.4M Buy
+155,894
New +$17.9M 0.59% 53

Other funds holding ELGX

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

PFM Health Sciences's ELGX Position: Q1 2020 in Review

PFM Health Sciences sold out of Endologix Inc (ELGX) in Q1 2020, closing a stake of 159,285 shares — an estimated $252K sold.

PFM Health Sciences first reported a position in ELGX in Q2 2016 and held it in 12 quarters. The position peaked at $42.7M in Q2 2018. 50 funds tracked by Wall St. Rank hold ELGX as of Q1 2020.

  • PFM Health Sciences reported no remaining Endologix Inc position as of Q1 2020 after selling out during the quarter.
  • PFM Health Sciences sold 159,285 Endologix Inc shares in Q1 2020, an estimated $252K.
  • PFM Health Sciences first reported a position in Endologix Inc in Q2 2016 and held it in 12 quarters.
  • PFM Health Sciences's Endologix Inc position peaked at $42.7M in Q2 2018.
  • 50 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2020.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.